Holen Sie sich die Stockscreener-App
2.115
4.25%
-0.12
Schlusskurs vom Vortag:
$2.235
Offen:
$2.2
24-Stunden-Volumen:
1.35M
Relative Volume:
0.25
Marktkapitalisierung:
$268.79M
Einnahmen:
$4.21M
Nettoeinkommen (Verlust:
$-97.67M
KGV:
-2.2742
EPS:
-0.93
Netto-Cashflow:
$-70.76M
1W Leistung:
-20.74%
1M Leistung:
-34.56%
6M Leistung:
-44.85%
1J Leistung:
-61.72%
1-Tages-Spanne:
$2.01
$2.22
1-Wochen-Bereich:
$2.01
$2.615
52-Wochen-Spanne:
$2.01
$6.72
Absci Corp Stock (ABSI) Company Profile
Firmenname
Absci Corp
Sektor
Branche
Telefon
(360) 949-1041
Adresse
18105 SE MILL PLAIN BLVD, VANCOUVER
Vergleichen Sie ABSI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABSI
Absci Corp
|
2.125 | 268.79M | 4.21M | -97.67M | -70.76M | -0.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
487.07 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
593.05 | 65.79B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
571.87 | 35.18B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
248.79 | 32.67B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
243.33 | 26.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Absci Corp Stock (ABSI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-22 | Eingeleitet | Needham | Buy |
| 2024-10-02 | Eingeleitet | Guggenheim | Buy |
| 2024-07-03 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-03-14 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-12-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-05-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2022-07-18 | Eingeleitet | Truist | Buy |
| 2022-03-02 | Fortgesetzt | Cowen | Market Perform |
| 2022-02-01 | Eingeleitet | Berenberg | Buy |
| 2021-11-10 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | BofA Securities | Neutral |
| 2021-08-16 | Eingeleitet | Cowen | Market Perform |
| 2021-08-16 | Eingeleitet | Credit Suisse | Outperform |
| 2021-08-16 | Eingeleitet | Stifel | Hold |
Alle ansehen
Absci Corp Aktie (ABSI) Neueste Nachrichten
Absci Corporation: A Potential Turnaround Play In Biotech Amid A Tumultuous Market - Seeking Alpha
Absci stock touches 52-week low at $2.45 amid market challenges - Investing.com
Which Healthcare Stock Is the Best Buy Right Now? - MarketBeat
Absci to Participate in Upcoming Investor Conferences - MarketScreener
Royce & Associates LP Grows Stake in Absci Co. (NASDAQ:ABSI) - MarketBeat
HC Wainwright Issues Negative Estimate for Absci Earnings - MarketBeat
Absci Corp’s Earnings Call: Balancing Innovation and Financial Challenges - MSN
KeyBanc maintains Absci stock Overweight rating, $5 target By Investing.com - Investing.com South Africa
KeyBanc maintains Absci stock Overweight rating, $5 target - Investing.com
Platinum Investment Management Ltd. Boosts Holdings in Absci Co. (NASDAQ:ABSI) - MarketBeat
Absci (NASDAQ:ABSI) Earns Buy Rating from Guggenheim - MarketBeat
Absci (NASDAQ:ABSI) Given "Buy" Rating at HC Wainwright - MarketBeat
Absci (NASDAQ:ABSI) Given Buy Rating at Needham & Company LLC - MarketBeat
Absci (NASDAQ:ABSI) Releases Quarterly Earnings Results - MarketBeat
Absci (NASDAQ:ABSI) Announces Earnings Results - MarketBeat
Absci Corporation (NASDAQ:ABSI) Q4 2024 Earnings Call Transcript - Insider Monkey
Cathie Wood's Ark Invest Scoops Up Iridium, Beam, Pacific Biosciences While Offloading Illumina And Amgen - Benzinga
Absci Corp (ABSI) Q4 2024: Everything You Need To Know Ahead Of Earnings - GuruFocus
Nikko Asset Management Americas Inc. Boosts Stock Position in Absci Co. (NASDAQ:ABSI) - MarketBeat
H.C. Wainwright maintains $7 target on Absci stock with Buy rating - Investing.com Australia
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips By Investing.com - Investing.com Australia
Absci Posts Downbeat Results, Joins HealthEquity, Tonix Pharmaceuticals And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Benzinga
A Glimpse Into The Expert Outlook On Absci Through 7 Analysts - Benzinga
Why StoneCo Shares Are Trading Higher By 8%; Here Are 20 Stocks Moving Premarket - Benzinga India
Absci Corp (ABSI) Q4 2024 Earnings Call Highlights: Strategic Collaborations and Financial ... By GuruFocus - Investing.com Canada
Absci Corp. Reports 2024 Earnings and Strategic Advances - TipRanks
Earnings call transcript: Absci Q4 2024 revenue misses, stock dips - Investing.com
Absci earnings missed by $0.03, revenue fell short of estimates - Investing.com
Absci Corp reports results for the quarter ended December 31Earnings Summary - TradingView
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Absci shares tumble as Q4 revenue falls short of estimates - Investing.com
Absci Corp SEC 10-K Report - TradingView
Absci reports Q4 EPS (25c), consensus (22c) - TipRanks
AMD Backs Absci With $20M Investment as AI Drug Platform Advances to Clinical Trials - StockTitan
AbSci Corp options imply 16.5% move in share price post-earnings - TipRanks
Earnings Scheduled For March 18, 2025 - Benzinga
Absci (ABSI) Expected to Announce Quarterly Earnings on Tuesday - MarketBeat
Absci (ABSI) Projected to Post Earnings on Tuesday - Defense World
Rhumbline Advisers Grows Stake in Absci Co. (NASDAQ:ABSI) - Defense World
Cathie Wood-Led Ark Invest Offloads Roblox, Roku, UiPath As Markets Take A Dip - Benzinga
Finanzdaten der Absci Corp-Aktie (ABSI)
Umsatz
Nettogewinn
Free Cashflow
ENV
Absci Corp-Aktie (ABSI) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Jonasson Zachariah | CFO / CBO |
Jun 13 '24 |
Sale |
4.98 |
19,859 |
98,892 |
384,751 |
| Phoenix Venture Partners II LP | 10% Owner |
May 22 '24 |
Sale |
4.40 |
3,100,000 |
13,640,000 |
11,279,522 |
2.65%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):